At present, the GLP-1 receptor agonists exendin-4 (Exenatide, Byetta , Bydureon ) (44, 45), liraglutide (Victoza ) (46), albiglutide [Eperzan (EU) Tanzeum (US)] (47, 48), dulaglutide (Trulicity ) (49), lixisenatide (Lyxumia , Adlyxin ) (50), semaglutide (Ozempic , Rybelsus ) (51, 52), are approved to treat T2DM (53) (see Table 1)
Additional questions from the MM15 Virtual Summit can be found in our accompanying article here: [insert article link] Access the full MM15 Course here: Mastermind 15 on Aesthetics Peptide Therapy Foundations: Sleep Hygiene This course examines the peptides connected to sleep and the nighttime environment: the agents studied for their influence on sleep architecture, melatonin signaling, and the restorative processes that occur overnight
5:e243685
00:12:18 Jennifer Trujillo But I havent seen any direct reports of these medications causing extreme anxiety or mood changes